Carl Zeiss Meditec AG (AFX.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold AFX.DE in your mock portfolio yet.
With EPS of €1.61 and a PE of 16.16, Carl Zeiss Meditec AG appears reasonably valued relative to earnings, suggesting neither clear undervaluation nor overvaluation based solely on these metrics. Profitability exists but the modest multiple implies the market is not pricing in aggressive growth, pointing to a balanced risk‑reward profile at current fundamentals.
The stock trades at €26.02, materially below its 200‑day moving average of €35.69, signaling a pronounced downtrend. A 6.7% decline over the last month reinforces negative momentum, and the large gap to the long‑term average suggests sentiment and technicals are currently unfavorable.
Alternative data points to a company that is actively growing its digital footprint and operational capacity, despite recent share price weakness. Rising job openings, steady app downloads, and generally expanding social media audiences suggest ongoing investment and engagement that are more consistent with a constructive medium‑term outlook.
Fundamentals and alternative data for Carl Zeiss Meditec AG appear reasonably solid, but the stock is in a clear technical downtrend and trades well below its long‑term moving average. Overall, the picture is neutral: operational and engagement indicators are constructive, yet price action and sentiment remain weak, leaving the balance between risk and opportunity finely poised.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started